The expanding field of targeted treatment relies heavily on recombinant mediator technology, and a thorough understanding of individual profiles is essential for refining experimental design and therapeutic efficacy. https://bookmark-template.com/story27292987/analyzing-recombinant-cytokine-profiles-il-1a-il-1b-il-2-and-il-3